Stay updated on Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial page
- CheckyesterdayChange DetectedDifference0.1%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version of the study (v2.15.0) and includes the addition of specific medical terms related to urothelial carcinoma, while significant background information and eligibility criteria have been removed.SummaryDifference55%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
Stay in the know with updates to Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial page.